Literature DB >> 8971158

Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers.

K Uchida1, M Nagatake, H Osada, Y Yatabe, M Kondo, T Mitsudomi, A Masuda, T Takahashi, T Takahashi.   

Abstract

The chromosome region 18q21 is frequently deleted in lung cancers. Recent identification of JV18-1 at this locus led us to examine whether or not it might also be altered in lung cancers, as is the case for the closely related DPC4 tumor suppressor gene. A missense somatic mutation and a 9-bp in-frame deletion were detected in the highly conserved region of JV18-1 among 57 lung cancer specimens taken directly from patients. The total alterations in JV18-1 and DPC4, however, are not sufficient to account for all 18q21 deletions in lung cancers. These findings suggest that although JV18-1 and DPC4 may play roles in a limited fraction of lung cancers, another tumor suppressor gene may also exist in this chromosome region.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8971158

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

1.  Influence of TGFB1+869T>C functional polymorphism in non-small cell lung cancer (NSCLC) risk.

Authors:  Ana L Teixeira; António Araújo; Ana Coelho; Ricardo Ribeiro; Mónica Gomes; Carina Pereira; Rui Medeiros
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-07       Impact factor: 4.553

Review 2.  Smad4 transcriptional pathways and angiogenesis.

Authors:  Irmgard Schwarte-Waldhoff; Wolff Schmiegel
Journal:  Int J Gastrointest Cancer       Date:  2002

3.  Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis.

Authors:  J Heyer; D Escalante-Alcalde; M Lia; E Boettinger; W Edelmann; C L Stewart; R Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Mechanism for mutational inactivation of the tumor suppressor Smad2.

Authors:  C Prunier; N Ferrand; B Frottier; M Pessah; A Atfi
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

5.  SMAD family member 3 (SMAD3) and SMAD4 repress HIF2α-dependent iron-regulatory genes.

Authors:  Xiaoya Ma; Nupur K Das; Cristina Castillo; Ayla Gourani; Ansu O Perekatt; Michael P Verzi; Yatrik M Shah
Journal:  J Biol Chem       Date:  2019-01-18       Impact factor: 5.157

6.  Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.

Authors:  F Liu; C Pouponnot; J Massagué
Journal:  Genes Dev       Date:  1997-12-01       Impact factor: 11.361

7.  Mutation and expression of the DCC gene in human lung cancer.

Authors:  T Kohno; T Sato; S Takakura; K Takei; K Inoue; M Nishioka; J Yokota
Journal:  Neoplasia       Date:  2000 Jul-Aug       Impact factor: 5.715

8.  Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice.

Authors:  Felix Beuschlein; Brendan D Looyenga; Stephanie E Bleasdale; Chris Mutch; David L Bavers; Albert F Parlow; John H Nilson; Gary D Hammer
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

9.  Smad2 functions as a co-activator of canonical Wnt/beta-catenin signaling pathway independent of Smad4 through histone acetyltransferase activity of p300.

Authors:  Morihisa Hirota; Kazuhide Watanabe; Shin Hamada; Youping Sun; Luigi Strizzi; Mario Mancino; Tadahiro Nagaoka; Monica Gonzales; Masaharu Seno; Caterina Bianco; David S Salomon
Journal:  Cell Signal       Date:  2008-05-18       Impact factor: 4.315

10.  Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.

Authors:  Wanglong Qiu; Frank Schönleben; Xiaojun Li; Gloria H Su
Journal:  Cancer Lett       Date:  2006-02-14       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.